{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T22:07:01Z","timestamp":1762898821304},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1097\/mnm.0b013e328355990f","type":"journal-article","created":{"date-parts":[[2012,6,13]],"date-time":"2012-06-13T01:28:09Z","timestamp":1339550889000},"page":"889-894","source":"Crossref","is-referenced-by-count":17,"title":["[18F]choline positron emission tomography in prostate cancer patients with biochemical recurrence after radical prostatectomy"],"prefix":"10.1097","volume":"33","author":[{"given":"Benjamin","family":"Henninger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Vesco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Putzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Kendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Loizides","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reto J.","family":"Bale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene J.","family":"Virgolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-13-20210212","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"R2-13-20210212","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/s00432-006-0132-6","article-title":"The addition of bicalutamide 150 mg to radiotherapy significantly improves overall survival in men with locally advanced prostate cancer.","volume":"132","author":"See","year":"2006","journal-title":"J Cancer Res Clin Oncol"},{"key":"R3-13-20210212","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0022-5347(05)63946-8","article-title":"Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.","volume":"169","author":"Han","year":"2003","journal-title":"J Urol"},{"key":"R4-13-20210212","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0090-4295(02)02526-8","article-title":"Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database.","volume":"61","author":"Freedland","year":"2003","journal-title":"Urology"},{"key":"R5-13-20210212","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1159\/000474350","article-title":"Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimens.","volume":"24","author":"Hellstrom","year":"1993","journal-title":"Eur Urol"},{"key":"R6-13-20210212","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1148\/radiology.218.2.r01ja04365","article-title":"Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with mr imaging.","volume":"218","author":"Padhani","year":"2001","journal-title":"Radiology"},{"key":"R7-13-20210212","first-page":"990","article-title":"PET imaging of prostate cancer using carbon-11-choline.","volume":"39","author":"Hara","year":"1998","journal-title":"J Nucl Med"},{"key":"R8-13-20210212","first-page":"110","article-title":"Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer.","volume":"61","author":"DeGrado","year":"2001","journal-title":"Cancer Res"},{"key":"R9-13-20210212","first-page":"187","article-title":"Development of (18)F-fluoroethylcholine for cancer imaging with PET: synthesis, biochemistry, and prostate cancer imaging.","volume":"43","author":"Hara","year":"2002","journal-title":"J Nucl Med"},{"key":"R10-13-20210212","first-page":"1805","article-title":"Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.","volume":"42","author":"DeGrado","year":"2001","journal-title":"J Nucl Med"},{"key":"R11-13-20210212","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.nucmedbio.2007.11.008","article-title":"Fully automated 18Ffluorocholine synthesis in the TracerLab MX FDG Coincidence Synthesizer.","volume":"35","author":"Kryza","year":"2008","journal-title":"Nucl Med Biol"},{"key":"R13-13-20210212","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2967\/jnumed.108.060236","article-title":"Bone metastases in patients with neuroendocrine tumor: 68Ga-DOTA-Tyr3-octreotide PET in comparison to CT and bone scintigraphy.","volume":"50","author":"Putzer","year":"2009","journal-title":"J Nucl Med"},{"key":"R14-13-20210212","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.semnuclmed.2007.07.003","article-title":"Cancer imaging with fluorine-18-labeled choline derivatives.","volume":"37","author":"Kwee","year":"2007","journal-title":"Semin Nucl Med"},{"key":"R15-13-20210212","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/MNM.0b013e328330adc5","article-title":"18F-choline PETCT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.","volume":"31","author":"Schillaci","year":"2010","journal-title":"Nucl Med Commun"},{"key":"R16-13-20210212","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1148\/radiol.2352040494","article-title":"Fluorocholine PETCT in patients with prostate cancer: initial experience.","volume":"235","author":"Schmid","year":"2005","journal-title":"Radiology"},{"key":"R17-13-20210212","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","article-title":"Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy.","volume":"51","author":"Simmons","year":"2007","journal-title":"Eur Urol"},{"key":"R18-13-20210212","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1).","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R19-13-20210212","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","article-title":"Predictive factors of (11)Ccholine PETCT in patients with biochemical failure after radical prostatectomy.","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R20-13-20210212","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00259-007-0552-9","article-title":"Evaluation of (18)F-choline PETCT for staging and restaging of prostate cancer.","volume":"35","author":"Husarik","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R22-13-20210212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00259-007-0581-4","article-title":"The detection rate of 11Ccholine-PETCT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.","volume":"35","author":"Krause","year":"2008","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R23-13-20210212","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1111\/j.1464-410X.2007.06772.x","article-title":"18F-choline andor 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (1 ngmL) after radical prostatectomy.","volume":"99","author":"Vees","year":"2007","journal-title":"BJU Int"},{"key":"R24-13-20210212","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1095-0397(00)00059-5","article-title":"9:30-9:45. Preliminary evaluation of F-18 fluorocholine (FCH) as a PET tumor imaging agent.","volume":"3","author":"Coleman","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"R25-13-20210212","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.nucmedbio.2006.08.002","article-title":"Effect of hypoxia on the uptake of methyl-3Hcholine, 1-14Cacetate and 18FFDG in cultured prostate cancer cells.","volume":"33","author":"Hara","year":"2006","journal-title":"Nucl Med Biol"},{"key":"R26-13-20210212","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0022-5347(05)64906-3","article-title":"Comparison of 18Ffluorocholine and 18Ffluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.","volume":"168","author":"Price","year":"2002","journal-title":"J Urol"},{"key":"R28-13-20210212","first-page":"95","article-title":"PETCT with (11)C-choline and (18)F-FDG in patients with elevated PSA after radical treatment of a prostate cancer.","volume":"28","author":"Garcia","year":"2009","journal-title":"Rev Esp Med Nucl"},{"key":"R29-13-20210212","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1007\/s00259-006-0150-2","article-title":"18Ffluorocholine PETCT imaging for the detection of recurrent prostate cancer at PSA relapse: experience in 100 consecutive patients.","volume":"33","author":"Cimitan","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0b013e328355990f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:42:35Z","timestamp":1620963755000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-201208000-00013"}},"subtitle":["influence of antiandrogen therapy \u2013 a preliminary study"],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328355990f","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}